$AH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in R1 RCM INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in R1 RCM INC.. Get notifications about new insider transactions in R1 RCM INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2018 | AH | R1 RCM INC. | Feiner Michael C. | Director | Option Exercise | A | 0.00 | 8,197 | 0 | 8,197 | |
| May 31 2018 | AH | R1 RCM INC. | Feiner Michael C. | Director | Option Exercise | A | 7.93 | 18,341 | 145,444 | 18,341 | |
| May 31 2018 | AH | R1 RCM INC. | Ditkoff Charles J. | Director | Option Exercise | A | 0.00 | 4,099 | 0 | 4,099 | |
| May 31 2018 | AH | R1 RCM INC. | Ditkoff Charles J. | Director | Option Exercise | A | 7.93 | 27,512 | 218,170 | 27,512 | |
| May 08 2018 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Payment of Exercise | F | 7.98 | 1,736 | 13,853 | 273,758 | 275.5 K to 273.8 K (-0.63 %) |
| Apr 03 2018 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 7.07 | 4,770 | 33,724 | 4,770 | |
| Apr 03 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 7.07 | 6,360 | 44,965 | 6,360 | |
| Apr 02 2018 | AH | R1 RCM INC. | TCP-ASC ACHI Series LLLP | Director | Option Exercise | A | 2.50 | 4,640 | 11,600 | 236,672 | |
| Feb 16 2018 | AH | R1 RCM INC. | Evans Richard B. Jr. | Principal Accountin ... | Payment of Exercise | F | 5.28 | 9,023 | 47,641 | 64,785 | 73.8 K to 64.8 K (-12.22 %) |
| Feb 16 2018 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Payment of Exercise | F | 5.28 | 14,213 | 75,045 | 275,494 | 289.7 K to 275.5 K (-4.91 %) |
| Feb 16 2018 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President and CEO | Option Exercise | A | 0.00 | 245,868 | 0 | 245,868 | |
| Feb 16 2018 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President and CEO | Payment of Exercise | F | 5.28 | 113,061 | 596,962 | 1,184,996 | 1.3 M to 1.2 M (-8.71 %) |
| Dec 21 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Option Exercise | A | 0.00 | 553,206 | 0 | 553,206 | |
| Dec 21 2017 | AH | R1 RCM INC. | SHULMAN STEVEN J | Director | Option Exercise | A | 0.00 | 1,475,208 | 0 | 1,475,208 | |
| Dec 21 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President and CEO | Option Exercise | A | 0.00 | 2,581,614 | 0 | 2,581,614 | |
| Nov 21 2017 | AH | R1 RCM INC. | Evans Richard B. Jr. | Principal Accountin ... | Option Exercise | A | 0.00 | 92,978 | 0 | 92,978 | |
| Nov 21 2017 | AH | R1 RCM INC. | LONG GARY STEVEN | Chief Commercial Of ... | Option Exercise | A | 0.00 | 107,333 | 0 | 107,333 | |
| Nov 21 2017 | AH | R1 RCM INC. | LESICA THOMAS A | Chief Operating Off ... | Option Exercise | A | 0.00 | 184,426 | 0 | 184,426 | |
| Oct 03 2017 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 3.76 | 9,169 | 34,475 | 9,169 | |
| Oct 03 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 3.76 | 12,225 | 45,966 | 12,225 | |
| Sep 18 2017 | AH | R1 RCM INC. | Ditkoff Charles J. | Director | Option Exercise | A | 0.00 | 20,635 | 0 | 20,635 | |
| Sep 18 2017 | AH | R1 RCM INC. | Ditkoff Charles J. | Director | Option Exercise | A | 3.15 | 47,550 | 149,783 | 47,550 | |
| Sep 18 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 0.00 | 41,270 | 0 | 41,270 | |
| Sep 18 2017 | AH | R1 RCM INC. | Feiner Michael C. | Director | Option Exercise | A | 0.00 | 10,318 | 0 | 10,318 | |
| Sep 18 2017 | AH | R1 RCM INC. | Feiner Michael C. | Director | Option Exercise | A | 3.15 | 71,325 | 224,674 | 71,325 | |
| Jul 05 2017 | AH | R1 RCM INC. | TCP-ASC ACHI Series LLLP | Director | Option Exercise | A | 2.50 | 4,373 | 10,933 | 223,023 | |
| Jun 13 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President and CEO | Option Exercise | A | 3.85 | 279,387 | 1,075,640 | 279,387 | |
| Jun 13 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President and CEO | Option Exercise | D | 11.47 | 800,000 | 9,176,000 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Option Exercise | A | 3.85 | 117,671 | 453,033 | 117,671 | |
| Jun 13 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Option Exercise | D | 6.15 | 31,875 | 196,031 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Option Exercise | D | 9.30 | 200,000 | 1,860,000 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | Evans Richard B. Jr. | Principal Accountin ... | Option Exercise | A | 3.85 | 41,020 | 157,927 | 41,020 | |
| Jun 13 2017 | AH | R1 RCM INC. | Evans Richard B. Jr. | Principal Accountin ... | Option Exercise | D | 5.84 | 50,000 | 292,000 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | Ditkoff Charles J. | Director | Option Exercise | A | 3.85 | 170,728 | 657,303 | 170,728 | |
| Jun 13 2017 | AH | R1 RCM INC. | Ditkoff Charles J. | Director | Option Exercise | D | 5.41 | 193,237 | 1,045,412 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 3.85 | 72,256 | 278,186 | 72,256 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 5.45 | 5,496 | 29,953 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 5.71 | 5,324 | 30,400 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 6.55 | 4,598 | 30,117 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 7.90 | 3,793 | 29,965 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 8.00 | 3,743 | 29,944 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 8.38 | 3,559 | 29,824 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 9.45 | 109,473 | 1,034,520 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | SHULMAN STEVEN J | Director | Option Exercise | A | 3.85 | 40,305 | 155,174 | 40,305 | |
| Jun 13 2017 | AH | R1 RCM INC. | SHULMAN STEVEN J | Director | Option Exercise | D | 10.38 | 103,174 | 1,070,946 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | SHULMAN STEVEN J | Director | Sell | D | 0.00 | 500,000 | 0 | 1,950,000 | 2.5 M to 2 M (-20.41 %) |
| Jun 06 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 3.75 | 3,795 | 14,231 | 1,298,057 | 1.3 M to 1.3 M (-0.29 %) |
| May 08 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Payment of Exercise | F | 3.89 | 1,843 | 7,169 | 289,707 | 291.6 K to 289.7 K (-0.63 %) |
| May 04 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 3.88 | 3,809 | 14,779 | 1,301,852 | 1.3 M to 1.3 M (-0.29 %) |
| Apr 06 2017 | AH | R1 RCM INC. | TCP-ASC ACHI Series LLLP | Director | Option Exercise | A | 2.50 | 4,287 | 10,718 | 218,650 | |
| Apr 05 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 3.08 | 3,809 | 11,732 | 1,305,661 | 1.3 M to 1.3 M (-0.29 %) |
| Apr 05 2017 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 3.08 | 10,512 | 32,377 | 10,512 | |
| Apr 05 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 3.08 | 14,016 | 43,169 | 14,016 | |
| Mar 07 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.43 | 2,592 | 6,299 | 1,309,470 | 1.3 M to 1.3 M (-0.20 %) |
| Feb 21 2017 | AH | R1 RCM INC. | Evans Richard B. Jr. | Principal Accountin ... | Payment of Exercise | F | 2.35 | 10,192 | 23,951 | 73,808 | 84 K to 73.8 K (-12.13 %) |
| Feb 21 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Payment of Exercise | F | 2.35 | 15,044 | 35,353 | 291,550 | 306.6 K to 291.6 K (-4.91 %) |
| Feb 21 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.35 | 98,448 | 231,353 | 1,312,062 | 1.4 M to 1.3 M (-6.98 %) |
| Feb 07 2017 | AH | R1 RCM INC. | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.30 | 3,034 | 6,978 | 1,410,510 | 1.4 M to 1.4 M (-0.21 %) |
| Jan 25 2017 | AH | R1 RCM INC. | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Payment of Exercise | F | 2.28 | 5,308 | 12,102 | 306,594 | 311.9 K to 306.6 K (-1.70 %) |
| Jan 05 2017 | AH | R1 RCM INC. | TCP-ASC ACHI Series LLLP | Director | Option Exercise | A | 2.50 | 4,203 | 10,508 | 214,363 | |
| Jan 04 2017 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.29 | 3,034 | 6,948 | 1,413,544 | 1.4 M to 1.4 M (-0.21 %) |
| Jan 04 2017 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.29 | 14,098 | 32,284 | 14,098 | |
| Jan 04 2017 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.29 | 18,797 | 43,045 | 18,797 | |
| Dec 12 2016 | AH | Accretive Health, ... | Evans Richard B. Jr. | Principal Accountin ... | Option Exercise | A | 2.42 | 164,852 | 398,942 | 164,852 | |
| Dec 12 2016 | AH | Accretive Health, ... | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Option Exercise | A | 2.42 | 408,696 | 989,044 | 408,696 | |
| Dec 12 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Option Exercise | A | 2.42 | 817,390 | 1,978,084 | 817,390 | |
| Dec 12 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Option Exercise | A | 2.42 | 1,634,780 | 3,956,168 | 1,634,780 | |
| Dec 06 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.26 | 3,809 | 8,608 | 1,416,578 | 1.4 M to 1.4 M (-0.27 %) |
| Nov 07 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.39 | 3,809 | 9,104 | 1,420,387 | 1.4 M to 1.4 M (-0.27 %) |
| Oct 05 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.42 | 18,349 | 44,405 | 18,349 | |
| Oct 05 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.42 | 13,762 | 33,304 | 13,762 | |
| Oct 05 2016 | AH | Accretive Health, ... | Evans Richard B. Jr. | Principal Accountin ... | Option Exercise | A | 2.42 | 41,213 | 99,735 | 41,213 | |
| Oct 05 2016 | AH | Accretive Health, ... | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Option Exercise | A | 2.42 | 204,348 | 494,522 | 204,348 | |
| Oct 05 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Option Exercise | A | 2.42 | 817,390 | 1,978,084 | 817,390 | |
| Oct 05 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.42 | 3,809 | 9,218 | 1,424,196 | 1.4 M to 1.4 M (-0.27 %) |
| Oct 04 2016 | AH | Accretive Health, ... | TCP-ASC ACHI Series LLLP | Director | Option Exercise | A | 2.50 | 6,120 | 15,300 | 210,160 | |
| Sep 07 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 1.93 | 3,809 | 7,351 | 1,428,005 | 1.4 M to 1.4 M (-0.27 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 12,500 | 22,500 | 50,000 | 37.5 K to 50 K (+33.33 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 1,500 | 2,700 | 37,500 | 36 K to 37.5 K (+4.17 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.81 | 14,500 | 26,245 | 36,000 | 21.5 K to 36 K (+67.44 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.81 | 1,500 | 2,715 | 21,500 | 20 K to 21.5 K (+7.50 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 10,000 | 17,975 | 20,000 | 10 K to 20 K (+100.00 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 7,800 | 14,040 | 10,000 | 2.2 K to 10 K (+354.55 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.79 | 500 | 895 | 2,200 | 1.7 K to 2.2 K (+29.41 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.77 | 500 | 885 | 1,700 | 1.2 K to 1.7 K (+41.67 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.79 | 500 | 893 | 1,200 | 700 to 1.2 K (+71.43 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.77 | 100 | 177 | 700 | 600 to 700 (+16.67 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.79 | 500 | 895 | 600 | 100 to 600 (+500.00 %) |
| Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.78 | 100 | 178 | 100 | 0 to 100 |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.72 | 6,201 | 10,666 | 2,450,000 | 2.4 M to 2.5 M (+0.25 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.71 | 3,799 | 6,496 | 2,443,799 | 2.4 M to 2.4 M (+0.16 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.72 | 1,600 | 2,752 | 2,440,000 | 2.4 M to 2.4 M (+0.07 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.72 | 150,000 | 258,000 | 2,438,400 | 2.3 M to 2.4 M (+6.55 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.70 | 15,900 | 27,030 | 2,288,400 | 2.3 M to 2.3 M (+0.70 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.69 | 2,500 | 4,225 | 2,272,500 | 2.3 M to 2.3 M (+0.11 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.54 | 4,400 | 6,776 | 2,270,000 | 2.3 M to 2.3 M (+0.19 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.52 | 5,000 | 7,600 | 2,265,600 | 2.3 M to 2.3 M (+0.22 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.52 | 100 | 152 | 2,260,600 | 2.3 M to 2.3 M (0.00 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.52 | 500 | 758 | 2,260,500 | 2.3 M to 2.3 M (+0.02 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 2,300 | 3,473 | 2,260,000 | 2.3 M to 2.3 M (+0.10 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 2,500 | 3,775 | 2,257,700 | 2.3 M to 2.3 M (+0.11 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 2,500 | 3,775 | 2,255,200 | 2.3 M to 2.3 M (+0.11 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 100 | 151 | 2,252,700 | 2.3 M to 2.3 M (0.00 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 100 | 151 | 2,252,600 | 2.3 M to 2.3 M (0.00 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 2,000 | 3,020 | 2,252,500 | 2.3 M to 2.3 M (+0.09 %) |
| Aug 11 2016 | AH | Accretive Health, ... | SHULMAN STEVEN J | Director | Buy | P | 1.51 | 500 | 753 | 2,250,500 | 2.3 M to 2.3 M (+0.02 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.55 | 20,000 | 31,000 | 200,000 | 180 K to 200 K (+11.11 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.54 | 1,000 | 1,540 | 180,000 | 179 K to 180 K (+0.56 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.53 | 5,000 | 7,650 | 179,000 | 174 K to 179 K (+2.87 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.80 | 25,001 | 45,002 | 174,000 | 149 K to 174 K (+16.78 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.79 | 5,599 | 10,022 | 148,999 | 143.4 K to 149 K (+3.90 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 4,500 | 6,795 | 143,400 | 138.9 K to 143.4 K (+3.24 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.76 | 1,300 | 2,288 | 138,900 | 137.6 K to 138.9 K (+0.94 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.74 | 2,500 | 4,350 | 137,600 | 135.1 K to 137.6 K (+1.85 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.73 | 10,100 | 17,473 | 135,100 | 125 K to 135.1 K (+8.08 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.72 | 10,000 | 17,200 | 125,000 | 115 K to 125 K (+8.70 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.53 | 13,100 | 20,043 | 115,000 | 101.9 K to 115 K (+12.86 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 1,200 | 1,812 | 101,900 | 100.7 K to 101.9 K (+1.19 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 35,000 | 52,850 | 100,700 | 65.7 K to 100.7 K (+53.27 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 65,700 | 99,207 | 65,700 | 0 to 65.7 K |
| Aug 11 2016 | AH | Accretive Health, ... | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Buy | P | 1.56 | 100,000 | 156,000 | 311,902 | 211.9 K to 311.9 K (+47.19 %) |
| Aug 11 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Buy | P | 1.56 | 100,000 | 156,000 | 1,431,814 | 1.3 M to 1.4 M (+7.51 %) |
| Aug 04 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 1.90 | 3,809 | 7,237 | 1,331,814 | 1.3 M to 1.3 M (-0.29 %) |
| Jul 11 2016 | AH | Accretive Health, ... | TCP-ASC ACHI Series LLLP | Director | Option Exercise | A | 2.50 | 4,040 | 10,100 | 204,040 | |
| Jul 06 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.00 | 3,809 | 7,618 | 1,335,623 | 1.3 M to 1.3 M (-0.28 %) |
| Jul 06 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.00 | 15,385 | 30,770 | 15,385 | |
| Jul 06 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.00 | 20,513 | 41,026 | 20,513 | |
| Jun 07 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President, CEO and ... | Payment of Exercise | F | 2.10 | 3,809 | 7,999 | 1,339,432 | 1.3 M to 1.3 M (-0.28 %) |
| May 05 2016 | AH | Accretive Health, ... | RICAURTE CHRISTOPHER SIMON | Chief Financial Off ... | Payment of Exercise | F | 2.31 | 1,790 | 4,135 | 211,902 | 213.7 K to 211.9 K (-0.84 %) |
| May 05 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | President and COO | Payment of Exercise | F | 2.33 | 3,809 | 8,875 | 1,343,241 | 1.3 M to 1.3 M (-0.28 %) |
| Apr 06 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | Chief Operating Off ... | Payment of Exercise | F | 2.52 | 2,517 | 6,343 | 1,350,411 | 1.4 M to 1.4 M (-0.19 %) |
| Apr 05 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.53 | 12,048 | 30,481 | 12,048 | |
| Apr 05 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.53 | 16,064 | 40,642 | 16,064 | |
| Mar 14 2016 | AH | Accretive Health, ... | Rizk Emad T. | President and CEO | Payment of Exercise | F | 2.71 | 2,368 | 6,417 | 2,513,749 | 2.5 M to 2.5 M (-0.09 %) |
| Mar 14 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | Chief Operating Off ... | Payment of Exercise | F | 2.71 | 3,341 | 9,054 | 1,352,928 | 1.4 M to 1.4 M (-0.25 %) |
| Mar 14 2016 | AH | Accretive Health, ... | Csapo Peter P. | Treasurer and CFO | Payment of Exercise | F | 2.71 | 1,060 | 2,873 | 883,476 | 884.5 K to 883.5 K (-0.12 %) |
| Mar 07 2016 | AH | Accretive Health, ... | Evans Richard B. Jr. | Principal Accountin ... | Grant | A | 0.00 | 84,000 | 0 | 84,000 | 0 to 84 K |
| Mar 07 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | Chief Operating Off ... | Payment of Exercise | F | 2.58 | 2,812 | 7,255 | 1,356,269 | 1.4 M to 1.4 M (-0.21 %) |
| Feb 24 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.61 | 405,111 | 1,057,340 | 405,111 | |
| Feb 12 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | Chief Operating Off ... | Payment of Exercise | F | 2.43 | 4,026 | 9,783 | 1,247,568 | 1.3 M to 1.2 M (-0.32 %) |
| Feb 12 2016 | AH | Accretive Health, ... | Csapo Peter P. | Treasurer and CFO | Payment of Exercise | F | 2.43 | 1,086 | 2,639 | 859,500 | 860.6 K to 859.5 K (-0.13 %) |
| Feb 12 2016 | AH | Accretive Health, ... | Rizk Emad T. | President and CEO | Payment of Exercise | F | 2.43 | 2,369 | 5,757 | 2,458,904 | 2.5 M to 2.5 M (-0.10 %) |
| Apr 13 2016 | AH | Accretive Health, ... | Rizk Emad T. | President and CEO | Payment of Exercise | F | 2.44 | 2,369 | 5,780 | 2,511,380 | 2.5 M to 2.5 M (-0.09 %) |
| Apr 13 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | Chief Operating Off ... | Payment of Exercise | F | 2.44 | 3,361 | 8,201 | 1,347,050 | 1.4 M to 1.3 M (-0.25 %) |
| Apr 13 2016 | AH | Accretive Health, ... | Csapo Peter P. | Treasurer and CFO | Payment of Exercise | F | 2.44 | 1,060 | 2,586 | 882,416 | 883.5 K to 882.4 K (-0.12 %) |
| Jan 06 2016 | AH | Accretive Health, ... | BRONFMAN EDGAR JR | Director | Option Exercise | A | 3.20 | 10,938 | 35,002 | 10,938 | |
| Jan 06 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 3.20 | 12,500 | 40,000 | 12,500 | |
| Jan 05 2016 | AH | Accretive Health, ... | Rizk Emad T. | President and CEO | Grant | A | 0.00 | 1,500,000 | 0 | 2,578,067 | 1.1 M to 2.6 M (+139.14 %) |
| Jan 05 2016 | AH | Accretive Health, ... | Csapo Peter P. | Treasurer and CFO | Grant | A | 0.00 | 676,800 | 0 | 911,744 | 234.9 K to 911.7 K (+288.07 %) |
| Jan 05 2016 | AH | Accretive Health, ... | FLANAGAN JOSEPH GERARD | Chief Operating Off ... | Grant | A | 0.00 | 952,000 | 0 | 1,484,714 | 532.7 K to 1.5 M (+178.71 %) |